Author:
du Bois A.,Meier W.,Lück H.J.,Emons G.,Moebus V.,Schroeder W.,Costa S.,Bauknecht T.,Olbricht S.,Jackisch C.,Richter B.,Wagner U.
Reference29 articles.
1. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results;Piccart;J Natl Cancer Inst,2000
2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996
3. Cisplatin/paclitaxel vs carboplatin/paclitaxel in ovarian cancer: Update of an AGO trial;du Bois;Proc Am Soc Clin Oncol,1999
4. Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial (GOG 158);Ozols;Proc Am Soc Clin Oncol,1999
5. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer;Neijt;J Clin Oncol,2000
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献